In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody

Angelo Dinota, Pier Luigi Tazzari, Mariagrazia Michieli, Giuseppe Visani, Marco Gobbi, Andrea Bontadini, Cristina Tassi, Renato Fanin, Daniela Damiani, Maria Grandi, Stefano Pileri, Andrea Bolognesi, Fiorenzo Stirpe, Michele Baccarani, Tasaki Tsuruo, Sante Tura

Research output: Contribution to journalArticle

Abstract

Selective elimination of multidrug resistance-positive cells (LoVo/Dx) was obtained by using the monoclonal antibody MRK 16, which recognizes a surface epitope of the Mr 170,000 glycoprotein, and a sheep anti-mouse immunoglobulin antibody, conjugated to the ribosome-inactivating protein saporin 6. The killing was greatly decreased or even abolished by adding the monoclonal antibody at a 100-fold concentration. Both the MRK 16 and anti-mouse saporin 6 conjugate did not show any killing activity when they were used separately. In cell suspensions composed of 90% normal bone marrow cells and 10% multidrug resistance-positive cells, the monoclonal antibody MRK 16 followed by the anti-mouse immunotoxin caused the elimination of 99% multidrug resistance-positive cells, as revealed by immunofluorescence and immunocytochemistry as well as by a clonal assay. Human normal hematopoietic precursors (granulomonocytic colony-forming units, erythroid burst-forming units, and multipotent granulomonocytic, erythroid, and megakaryocytic-forming units) were not affected by the MRK 16 plus immunotoxin treatment. This technique might be suitable for ex vivo bone purging in an appropriate clinical setting, such as autologous bone marrow transplantation.

Original languageEnglish
Pages (from-to)4291-4294
Number of pages4
JournalCancer Research
Volume50
Issue number14
Publication statusPublished - Jul 15 1990

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against M<sub>r</sub> 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody'. Together they form a unique fingerprint.

  • Cite this

    Dinota, A., Tazzari, P. L., Michieli, M., Visani, G., Gobbi, M., Bontadini, A., Tassi, C., Fanin, R., Damiani, D., Grandi, M., Pileri, S., Bolognesi, A., Stirpe, F., Baccarani, M., Tsuruo, T., & Tura, S. (1990). In vitro bone marrow purging of multidrug-resistant cells with a mouse monoclonal antibody directed against Mr 170,000 glycoprotein and a saporin-conjugated anti-mouse antibody. Cancer Research, 50(14), 4291-4294.